|
|
Home > Healthcare > Medical > Insurance & Managed Care
Dealmaking and Industry Outlook: Geriatric Diseases
|
| Published Date:
May 2009
Published By:
Decision Resources
Page Count:
40
Order Code:
R55-641
|
|
|
|
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Introduction
- Trends in Elderly Populations
- Population Growth and Life Expectancy
- The Cost of Living Longer
- National Health Expenditures in the United States: 1993-2018
- Personal Health Expenditures: Where Are We Spending Our Healthcare Money?
- Worldwide Pharmaceutical Market
- Diseases Affecting the Elderly
- Cardiovascular Therapy Area
- Metabolic Therapy Area
- Respiratory Therapy Area
- Musculoskeletal/Pain Therapy Area
- Rheumatoid Arthritis
- Neuropathic Pain
- Osteoarthritis
- Osteoporosis
- Central Nervous System Therapy Area
- Alzheimer’s Disease
- Parkinson’s Disease
- Genitourinary Therapy Area
- Erectile Dysfunction
- Urinary Incontinence
- Ophthalmology Therapy Area
- Oncology Therapy Area
- Healthcare Coverage for the Elderly
- United States
- France
- Germany
- Italy
- Spain
- United Kingdom
- Japan
- Decision Resources Analyst Insights
- Convenience and Compliance
- Determining Patient Genotypes
- Disease Progression and Biomarkers
- Disease-Modifying Therapies
- FDA Guidelines for Developers of Diabetes Drugs
- Lifestyle Drugs and Aging
- Multimorbidity
- Never Too Old
- Nothing Beats Innovation
- Nutrition
- Therapeutic Window
- Outlook
- Tables
- 1. Market-Leading Drugs and Promising Emerging Therapies in Cardiovascular Disease, and 2009
- 2. Market-Leading Drugs and Promising Emerging Therapies in Type 1 Diabetes, 2008 and 2009
- 3. Market-Leading Drugs and Promising Emerging Therapies in Respiratory Disorders, and 2009
- 4. Market-Leading Drugs and Promising Emerging Therapies in Musculoskeletal/Pain Disorders,2008 and 2009
- 5. Market-Leading Drugs and Promising Emerging Therapies in Central Nervous System Disorders,2008 and 2009
- 6. Market-Leading Drugs and Promising Emerging Therapies in Erectile Dysfunction, 2008 and 2009
- 7. Market-Leading Drugs and Promising Emerging Therapies in Age-Related Macular Degeneration,
- 2008 and 2009
- 8. Market-Leading Drugs and Promising Emerging Therapies in Oncology, 2008 and 2009
- 9. Major Pharmaceutical/Biotech Deals Affecting Geriatric Disorders, January 2005-March 2009
- Figures
- 1. Past, Current, and Projected Populations of People Aged 65 Years or Older in the Major Markets for Select Years, 1996-2050
- 2. Life Expectancy at Birth in the United States, Europe, and Japan for Select Years, 2000-2050
- 3. U.S. Life Expectancy at Birth, Age 65, and Age 85 for Select Years, 1900-2005
- 4. U.S. National Health Expenditures for Select Years, 1993-2018
- 5. U.S. National Health Expenditures by Source of Funds for Select Years, 1993-2018
- 6. Contributions of Select Therapeutic Areas and Preventive Care to U.S. Personal Health Expenditures for Select Years, 1996-2005
- 7. Worldwide Pharmaceutical Market, by Therapy Area, 2007
- 8. Percentage of People in the United States Aged 65 Years or Older with Self-Reported Chronic Health Conditions, 2005-2006
- 9. Market Share of Major Players in the Cardiovascular Therapy Area, 2007
- 10. Market Share of Major Players in the Metabolic Therapy Area, 2007
- 11. Market Share of Major Players in the Respiratory Therapy Area, 2007
- 12. Market Size and Major Players in the Musculoskeletal/Pain Therapy Area, 2007
- 13. Market Size and Major Players in the Central Nervous System Therapy Area, 2007
- 14. Market Size and Major Players in the Genitourinary Therapy Area, 2007
- 15. Market Size and Major Players in the Ophthalmology Therapy Area, 2007
- 16. Market Size and Major Players in the Oncology Therapy Area, 2007
|
Similar Products
• H4-13, Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009
Published Oct 2009 by Decision Resources
• Xerox Acquisition of ACS: Implications for the Healthcare Payer Market
Published Oct 2009 by IDC
• Australian Public Sector: Medicare Australia
Published Oct 2009 by Ovum Plc
• Dell and Perot Systems: Implications for the Healthcare Market
Published Oct 2009 by IDC
• Health & Welfare Funds in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Plunkett's Health Care Industry Trends and Statistics 2010 (Summary)
Published Oct 2009 by Plunkett Research, Ltd.
• Plunkett's Health Care Industry Almanac 2010
Published Oct 2009 by Plunkett Research, Ltd.
• 2010 U.S. Health & Medical Insurance Carriers Industry Report
Published Oct 2009 by Barnes Reports
• Express Scripts, Inc.
Published Oct 2009 by SGA Lists
|
|
|
|
0 items
